Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87,559Revenue $M19,616Net Margin (%)11.2Altman Z-Score4.0
Enterprise Value $M91,666EPS $2.2Operating Margin %16.0Piotroski F-Score4
P/E(ttm)38.1Beneish M-Score-2.6Pre-tax Margin (%)13.9Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %10.8Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %-6.0Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow35.6y-y EBITDA Growth Rate %-32.9ROA % (ttm)6.2Higher Current Ratio y-yN
Dividend Yield %2.5PEG--ROE % (ttm)13.0Less Shares Outstanding y-yY
Payout Ratio %96.0Shares Outstanding M1,110ROIC % (ttm)13.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYVanguard Health Care Fund 2015-03-31 Add0.45%$68.41 - $76.36
($71.19)
$ 78.9011%Add 13.24%24,892,160
LLYCharles Brandes 2015-03-31 Reduce-0.06%$68.41 - $76.36
($71.19)
$ 78.9011%Reduce 36.80%107,025
LLYKen Fisher 2015-03-31 Add0.03%$68.41 - $76.36
($71.19)
$ 78.9011%Add 37.46%795,909
LLYHOTCHKIS & WILEY 2015-03-31 Add0.01%$68.41 - $76.36
($71.19)
$ 78.9011%Add 0.70%3,968,039
LLYJoel Greenblatt 2015-03-31 Sold Out -0.0031%$68.41 - $76.36
($71.19)
$ 78.9011%Sold Out0
LLYDodge & Cox 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 78.9011%Reduce 7.10%36,234
LLYMario Gabelli 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 78.9011%Reduce 1.76%111,800
LLYCharles Brandes 2014-12-31 Reduce-1.85%$61.9 - $72.83
($67.53)
$ 78.9017%Reduce 92.65%169,348
LLYRichard Pzena 2014-12-31 Sold Out -0.15%$61.9 - $72.83
($67.53)
$ 78.9017%Sold Out0
LLYKen Fisher 2014-12-31 Add0.07%$61.9 - $72.83
($67.53)
$ 78.9017%Add 383.26%578,992
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 78.9025%Reduce 14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 78.9025%Reduce 10.92%4,321,666
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 78.9025%Sold Out0
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 78.9025%Reduce 84.40%900
LLYKen Fisher 2014-09-30 Add0.02%$60.35 - $66.59
($63.3)
$ 78.9025%Add 2742.47%119,810
LLYJoel Greenblatt 2014-09-30 Reduce$60.35 - $66.59
($63.3)
$ 78.9025%Reduce 27.37%5,628
LLYDodge & Cox 2014-09-30 Add$60.35 - $66.59
($63.3)
$ 78.9025%Add 20.38%42,464
LLYHOTCHKIS & WILEY 2014-06-30 Add0.73%$58.21 - $63.1
($59.62)
$ 78.9032%Add 199.70%4,851,480
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 78.9032%Reduce 3.98%21,982,700
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 78.9032%New holding50,441
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2015-05-20Sell190,000$73.437.45view
LILLY ENDOWMENT INC10% Owner 2015-05-15Sell200,000$72.838.33view
LILLY ENDOWMENT INC10% Owner 2015-05-08Sell195,000$73.287.67view
LILLY ENDOWMENT INC10% Owner 2015-05-01Sell200,000$73.097.95view
LILLY ENDOWMENT INC10% Owner 2015-03-30Sell180,000$73.946.71view
LILLY ENDOWMENT INC10% Owner 2015-03-23Sell190,000$76.972.51view
Fry Stephen FSVP, HR & Diversity 2015-03-09Sell4,000$69.2713.9view
Zakrowski Donald AChief Accounting Officer 2015-02-05Sell374$71.0311.08view
Ricks David ASVP and Pres, Lilly Bio-Meds 2015-02-04Sell3,147$69.9912.73view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-04Sell11,085$70.0812.59view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    MannKind Looks Good For Long Term Investors Apr 29 2015 
    What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
    Eli Lilly Inks Major Deal In China To Develop Oncology Segment Mar 23 2015 
    Box Inc. Declares Mixed Bag Q4 Results for 2015 Mar 13 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    FDA Approves Sanofi’s New Diabetes Drug Feb 27 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Sarah Ketterer Dives in when Others Pull Out Nov 14 2014 

    More From Other Websites
    BMY hit on disappointing drug trial May 29 2015
    Buying into biotech: 5 trades on 3 stocks May 29 2015
    At ASCO: Bristol, Merck Drugs Shrink Several Tumor Types May 29 2015
    Jim Cramer's Stop Trading: Lilly's AstraZeneca Partnership Is a ‘Brilliant’ Move May 29 2015
    Lilly to Participate in Goldman Sachs Global Healthcare Conference May 29 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Cyberark, Frontline, GameStop May 29 2015
    Lilly to Participate in Goldman Sachs Global Healthcare Conference May 29 2015
    Cramer's Stop Trading: Eli Lilly May 29 2015
    Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors May 29 2015
    Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors May 29 2015
    LILLY ELI & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 29 2015
    AstraZeneca and Lilly to test new cancer drug combination May 29 2015
    AstraZeneca and Lilly to test new cancer drug combination May 29 2015
    AstraZeneca and Lilly to collaborate on Immuno-oncology combination clinical trial in solid tumours May 29 2015
    1:25 am Eli Lilly prices cash tender offers for $1.6 bln of its outstanding debt securities May 29 2015
    Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate... May 28 2015
    Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate... May 28 2015
    Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data May 28 2015
    Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data May 28 2015
    Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data May 28 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK